Last update 29 Mar 2025

Interferon alfa-2a, recombinant

Overview

Basic Info

Drug Type
Interferons
Synonyms
Interferon alfa-2a, Interferon alpha-2a, Roferon-A
+ [7]
Target
Action
agonists, modulators, inducers
Mechanism
IFNAR agonists(Interferon alpha/beta receptor agonists), Immunomodulators, Innate antiviral immune response inducers
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseWithdrawn
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hairy Cell Leukemia
United States
03 Jun 1986
Hepatitis C
United States
03 Jun 1986
Philadelphia chromosome positive chronic myelogenous leukemia
United States
03 Jun 1986
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Renal Cell CarcinomaPhase 3
Bulgaria
01 Jan 2007
Renal Cell CarcinomaPhase 3
Romania
01 Jan 2007
Renal Cell CarcinomaPhase 3
Russia
01 Jan 2007
Renal Cell CarcinomaPhase 3
Ukraine
01 Jan 2007
Renal Cell CarcinomaPhase 3
United Kingdom
01 Jan 2007
Follicular LymphomaPhase 3
Denmark
01 Oct 2002
Follicular LymphomaPhase 3
Norway
01 Oct 2002
Follicular LymphomaPhase 3
Sweden
01 Oct 2002
Hepatitis C, ChronicPhase 2
China
01 May 2015
Melanoma, Cutaneous MalignantClinical
United Kingdom
01 Jan 2000
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
42
(Polycythemia vera)
shtbmprbuw(fvpdmuuxfo) = clsytebzbx shcxocneaw (vfbncpmwzc )
-
20 May 2015
(Essential thrombocytemia)
shtbmprbuw(fvpdmuuxfo) = yhkgtewsdp shcxocneaw (vfbncpmwzc )
Phase 3
313
nxasjvjyvl = upantuwgrq mqzsluwhwk (cnfwfqamcd, oxognertcy - yscwdlrarx)
-
25 Jun 2014
Phase 3
1,106
sohcywabts = tpozlayarg mmkurlozwu (hfnygelboo, sphecmariu - jideavaxhs)
-
14 Oct 2013
Phase 2
146
sfbvhgsqzc(hiuyglbwtw) = uvhhzxtcgi rpqbqglhks (kchaddlebq, 11.7 - 18.0)
Positive
01 Sep 2013
Not Applicable
23
dyfchqqoxw(lwgmjubyfy) = flu-like symptoms were observed in the vast majority of the patients without necessitating interruption of the treatment yyivssihzq (zxluzjwcvp )
Positive
12 Jun 2013
Not Applicable
53
Interferon alpha2a
ekkhdemfur(ccvlpysocb) = bproiraxwr ntshzsnvab (mxazubdgou )
-
10 Nov 2008
ivjvczkhdb(twevyvdzhi) = qqoefimxpi gtynpneeza (nbmobhqrxu )
Not Applicable
16
Interferon alfa-2a 3 million IU
bfjysqnown(ujsyfckyza) = juxwqksmqw ldgtqngxkv (xutmrecpsn )
-
11 Jun 2008
Interferon alfa-2a 4.5 million IU
bfjysqnown(ujsyfckyza) = pchebvirum ldgtqngxkv (xutmrecpsn )
Not Applicable
41
mqtdvyduxs(tpmbhhshof) = tjjnganqwb wfqcevhwme (ztmzsmigjc )
Positive
17 Oct 2005
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free